Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

PRPF39 Activators

PRPF39 Activators are a diverse set of chemical compounds that exert their effects by modulating various cellular pathways, ultimately leading to the enhancement of PRPF39's functional role in the pre-mRNA processing complex. For instance, certain activators function by elevating the levels of intracellular second messengers such as cAMP, which is known to influence a broad range of signaling pathways including those that govern the assembly and dynamics of the spliceosome. The increased cAMP levels could potentially enhance PRPF39 activity by facilitating its association with other spliceosomal components or by modulating its phosphorylation state. Other activators work by altering the cellular phosphorylation landscape, either through the activation of kinases such as protein kinase C or through the inhibition of phosphatases. These changes can lead to modifications in the spliceosomal components that interact with PRPF39, thereby enhancing its role in the intricate process of splicing.

Additionally, some activators increase intracellular calcium concentrations, a signal that plays a pivotal role in numerous cellular functions, including the regulation of enzyme activity and protein interactions within the spliceosome. This rise in calcium may indirectly promote the activation of PRPF39 by influencing its binding affinities or conformational state, which is crucial for the precise recognition and processing of pre-mRNA. Other activators achieve their effects by modulating specific lipid signaling pathways or by donating reactive molecules such as nitric oxide, which can diffuse across membranes and rapidly alter the activity of a wide spectrum of target proteins.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

Antagonizes adenosine receptors and indirectly increases neurotransmitter release, which may enhance PRPF39-mediated pre-mRNA processing events.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C, potentially influencing phosphorylation states and thus enhancing PRPF39 function in spliceosome assembly.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Raises intracellular calcium levels, potentially modulating calcium-dependent phosphorylation and thereby possibly increasing PRPF39 activity.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Inhibits protein phosphatases PP1 and PP2A, potentially altering the phosphorylation state of proteins and indirectly affecting PRPF39 activity.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

Calcium ionophore that increases intracellular calcium, which may influence phosphorylation events indirectly affecting PRPF39 function.

Sodium Orthovanadate

13721-39-6sc-3540
sc-3540B
sc-3540A
5 g
10 g
50 g
$49.00
$57.00
$187.00
142
(4)

Inhibits protein tyrosine phosphatases, potentially enhancing phosphorylation signaling pathways that could indirectly increase PRPF39 activity.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Beta-adrenergic agonist that can elevate cAMP levels, potentially leading to an upregulation of PRPF39 activity through cAMP-dependent pathways.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Inhibits glycogen synthase kinase 3 (GSK-3), which may lead to changes in phosphorylation patterns affecting PRPF39's role in mRNA processing.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

A bioactive lipid that activates sphingosine-1-phosphate receptors, potentially influencing signaling pathways that modulate PRPF39 activity.